Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,94
KB0,33
PKN63,9463,981,67
Msft-0,61
Nokia3,55453,7095-1,18
IBM-0,09
Mercedes-Benz Group AG60,1760,190,84
PFE-1,43
16.08.2024 23:33:45
Indexy online
AD Index online
select
AD Index online
 

  • 16.08.2024 17:31:02
COLTENE (CLTN.S, Swiss Exchange)
Poslední obchod Změna (%) Změna (CHF) Objem obchodů (CHF)
52,20 1,16 0,60 196 937
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.08.2024
Popis společnosti
Obecné informace
Název společnostiCOLTENE Holding AG
TickerCLTN
Kmenové akcie:Ordinary Shares
RICCLTN.S
ISINCH0025343259
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.06.2024
Počet zaměstnanců k 30.06.2024 1 191
Akcie v oběhu k 30.06.2024 5 975 318
MěnaCHF
Kontaktní informace
UliceFeldwiesenstrasse 20
MěstoALTSTAETTEN
PSČ9450
ZeměSwitzerland
Kontatní osobaMarkus Abderhalden
Funkce kontaktní osobyChief Financial Officer, Member of the Management Board
Telefon41 717 575 380
Fax41717575301
Kontatní telefon41 717 575 480

Business Summary: Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.
Financial Summary: BRIEF: For the six months ended 30 June 2024, COLTENE Holding AG revenues decreased 3% to SF127.5M. Net income increased 4% to SF10.4M. Revenues reflect Efficient Treatment segment decrease of 5% to SF47.3M, Infection Control segment decrease of 3% to SF43.4M, EMEA segment decrease of 5% to SF44.1M, Asia/Oceania segment decrease of 5% to SF13.9M. Net income reflects Financial income and expenses increase from SF1.2M (expense) to SF543K (income).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSDental Equipment and Supplies Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSOffices of Other Holding Companies
NAICS2007Dental Equipment & Supplies Mfg
NAICS2007Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICS2007Offices of Other Holding Companies
NAICS1997Dental Equipment and Supplies Manufacturing
NAICS1997Medical, Dental and Hospital Equipment and Supplies Wholesalers
NAICS1997Offices of Other Holding Companies
SICDental Equipment And Supplies
SICMedical And Hospital Equipment
SICHolding Companies, Nec



  • Poslední aktualizace: 16.08.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerDominik Arnold5201.04.2023
Chief Financial Officer, Member of the Management BoardMarkus Abderhalden4501.01.202201.01.2022
Chief Operating Officer, Member of the Management BoardGregor Picard5401.04.202301.04.2023
Vice President - Sales and Marketing Communication, North America and Member of the Management BoardPaul Frey4901.01.202201.01.2022
Vice President - Sales and Marketing Communication Europe, Row and Member of the Management BoardChristophe Loretan5401.01.202201.01.2022
Vice President - Product Management, Group Marketing and Member of the Management BoardWerner Barth58
Vice President - Research and Development, Innovation and Member of the Management BoardMartin Schlueter5201.01.202001.01.2020